Loading...
BVMF
DASA3
Market cap338mUSD
Jun 16, Last price  
1.49BRL
1D
-0.67%
1Q
-21.58%
Jan 2017
-91.58%
IPO
-74.62%
Name

Diagnosticos da America SA

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
0.12
EPS
—
Div Yield, %
—
Shrs. gr., 5y
30.93%
Rev. gr., 5y
28.55%
Revenues
15.32b
+7.51%
528,280,000670,450,000858,820,0001,137,525,0001,388,313,0001,501,967,0002,179,874,0002,264,142,0002,487,487,0002,697,573,0002,794,399,0003,040,775,0003,399,308,0003,933,451,0004,364,585,0007,039,331,00010,418,674,00013,128,893,00014,252,235,00015,322,079,000
Net income
-1.20b
L+2.83%
10,157,00016,511,00056,621,000-12,980,00084,997,00097,966,000145,255,00085,192,000131,301,00082,289,00023,813,00094,738,000131,443,000184,378,000124,777,000-147,739,000-216,937,000-387,766,000-1,166,016,000-1,198,990,000
CFO
28m
P
107,648,000132,873,000383,383,000338,606,000106,244,000195,293,000-25,643,000315,495,000254,980,000459,222,000494,329,000841,937,000653,235,000530,331,000699,366,000766,504,0001,298,179,0001,339,682,000-963,624,00027,946,000
Dividend
Dec 27, 20220.096871 BRL/sh
Earnings
Aug 12, 2025

Profile

Diagnósticos da América S.A. provides diagnostic test services in Latin America. It offers approximately 3,000 types of examinations of clinical analyses and diagnostic imaging services. The company also provides support services to approximately 5,000 laboratories under the Alvaro brand, as well as operates for the public sector under the CientíficaLab brand. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 17, 2000. The company was founded in 1966 and is based in Barueri, Brazil.
URL
https://www.dasa3.com.br/
IPO date
Nov 19, 2004
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
15,322,079
7.51%
14,252,235
8.56%
13,128,893
26.01%
Cost of revenue
14,315,555
13,340,533
10,556,864
Unusual Expense (Income)
NOPBT
1,006,524
911,702
2,572,029
NOPBT Margin
6.57%
6.40%
19.59%
Operating Taxes
128,572
133,816
(191,029)
Tax Rate
12.77%
14.68%
NOPAT
877,952
777,886
2,763,058
Net income
(1,198,990)
2.83%
(1,166,016)
200.70%
(387,766)
78.75%
Dividends
(10,083)
(159,241)
Dividend yield
0.41%
2.08%
Proceeds from repurchase of equity
1,592,857
1,565,765
(37,917)
BB yield
-65.07%
-21.79%
0.49%
Debt
Debt current
1,281,235
1,897,394
1,169,608
Long-term debt
14,308,530
14,040,425
14,241,726
Deferred revenue
Other long-term liabilities
1,302,449
1,827,574
1,788,959
Net debt
13,835,938
14,121,022
14,126,321
Cash flow
Cash from operating activities
27,946
(963,624)
1,339,682
CAPEX
(474,845)
(811,249)
(1,136,157)
Cash from investing activities
(373,593)
978,958
(1,599,800)
Cash from financing activities
503,215
284,868
1,770,765
FCF
386,859
246,758
592,456
Balance
Cash
1,895,329
1,664,755
1,285,013
Long term investments
(141,502)
152,042
Excess cash
987,723
1,104,185
628,568
Stockholders' equity
16,669,933
16,269,817
7,128,601
Invested Capital
21,243,761
21,351,836
21,219,316
ROIC
4.12%
3.65%
15.13%
ROCE
4.49%
4.06%
11.77%
EV
Common stock shares outstanding
1,288,356
747,048
558,184
Price
1.90
-80.25%
9.62
-29.93%
13.73
-59.31%
Market cap
2,447,876
-65.94%
7,186,602
-6.23%
7,663,866
-59.47%
EV
16,293,455
21,311,016
21,800,964
EBITDA
2,373,342
2,208,006
3,683,552
EV/EBITDA
6.87
9.65
5.92
Interest
1,688,791
1,907,732
1,601,770
Interest/NOPBT
167.78%
209.25%
62.28%